There were no significant differences in the median IgM level of acute serum samples of COVID-19 patients with convalescent-phase serum samples of COVID-19 patients or serum samples of patients with other infections or healthy donors (Fig 3A). This evidence concerns the gene CD40LG and COVID-19.